We must stay vigilant on false patent extensions and the non-clinical use of weight-loss drugs
Mounjaro, Eli Lilly’s brand of another weight-loss drug called tirzepatide, was launched this March. In just over half a year, it had toppled GlaxoSmithKline’s antibiotic Augmentin as India’s largest selling medicine by value, with sales reported at ₹100 crore in October. This reveals huge demand for drugs that promise to help people knock off weight.
Post Comment